Predictors of discontinuation in foslevodopa/foscarbidopa therapy for Parkinson's disease
- PMID: 40440953
- DOI: 10.1016/j.parkreldis.2025.107896
Predictors of discontinuation in foslevodopa/foscarbidopa therapy for Parkinson's disease
Conflict of interest statement
Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Noriko Nishikawa reports a relationship with AbbVie GK that includes: consulting or advisory and speaking and lecture fees. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Publication types
LinkOut - more resources
Full Text Sources